CLINICAL AND PARACLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES IN CHILDREN AGED 6-60 MONTHS WITH ACUTE ROTAVIRUS DIARRHEA RECEIVING RACECADOTRIL AT CAN THO CHILDREN’S HOSPITAL IN 2025-2026

Thi Nhan My Nguyen1,2, Quang Nghia Bui1, Thanh Lam Thai2, Nguyen Cong Khanh Tran2,
1 Can Tho University of Medicine and Pharmacy
2 Can Tho Children’s Hospital

Main Article Content

Abstract

Background: Acute diarrhea caused by Rotavirus is a common cause of hospitalization in young children. Racecadotril has been used as supportive treatment for acute diarrhea; however, findings across studies remain inconsistent, and data from the Can Tho region are limited. Objectives: To describe the clinical and paraclinical characteristics and to compare selected treatment outcomes between children with acute Rotavirus diarrhea who received racecadotril and those who did not. Materials and methods: A prospective observational cohort study with a comparison group was conducted on 87 children aged 6–60 months with acute Rotavirus diarrhea at Can Tho Children’s Hospital from April 2025 to January 2026. Clinical, paraclinical, and treatment outcome data were collected using a standardized study form. Rotavirus infection was confirmed by a positive ROTACHECK-1 rapid test. Data were analyzed using SPSS 18.0. The Mann–Whitney U test and independent-samples t-test were used, with statistical significance set at p<0.05. Results: Among 87 children, the 12–<24-month age group accounted for the highest proportion (67.8%). Forty-five children (51.7%) received racecadotril, while 42 children (48.3%) did not. The racecadotril group had a lower number of diarrheal episodes within 48 hours than the non-racecadotril group, with medians of 8 versus 9 episodes, respectively (p=0.046); a lower total volume of intravenous fluid, 360 mL versus 500 mL (p=0.011); and a shorter hospital stay, 5.31 ± 0.23 days versus 6.61 ± ROTA 0.23 days (p<0.001). No statistically significant differences were observed between the two groups in the number of vomiting episodes within 48 hours, duration of diarrhea, or duration of vomiting. Conclusion: Acute Rotavirus diarrhea mainly occurred in children aged 12–<24 months. Children who received racecadotril had fewer diarrheal episodes within 48 hours, lower intravenous fluid requirements, and shorter hospital stays than those who did not. Racecadotril may be con-sidered a supportive treatment option for acute Rotavirus diarrhea in children. 

Article Details

Author Biographies

Thi Nhan My Nguyen, Can Tho University of Medicine and Pharmacy, Can Tho Children’s Hospital

Bác sĩ Chuyên Khoa 1, Bệnh viện Nhi Đồng Cần Thơ

Quang Nghia Bui, Can Tho University of Medicine and Pharmacy

PGS.TS.BS. Bùi Quang Nghĩa, Trưởng bộ Môn Nhi, Trường Đại học Y Dược Cần Thơ

Thanh Lam Thai, Can Tho Children’s Hospital

Bác sĩ Chuyên Khoa 2, Trương Khoa Tiêu hóa, Bệnh viện Nhi Đồng Cần Thơ

References

1. WHO. Diarrhoea. Pocket book of primary health care for children and adolescents: guidelines for health promotion, disease prevention and management from the newborn period to adolescence. Copenhagen: WHO Regional Office for Europe. 2022. 271-299.
2. Bệnh viện Nhi Đồng 1. Phác đồ điều trị Nhi khoa 2020. Nhà xuất bản Y học. 2020.
3. Bộ Y tế. Tài liệu Hướng dẫn xử trí tiêu chảy ở trẻ em. Ban hành kèm theo Quyết định số 4121/QĐ-BYT ngày 28 tháng 10 năm 2009 của Bộ trưởng Bộ Y tế. 2009.
4. Trần Quang Khải, Nguyễn Thị Thanh Loan. Tác nhân vi sinh gây tiêu chảy cấp ở trẻ em tại Bệnh viện Đa khoa Vĩnh Long. Tạp chí Nghiên cứu Y học. 2024. 174(1), 117-125.
5. Du Y., Chen C., Zhang X. Global burden and trends of rotavirus infection-associated deaths from 1990 to 2019: an observational trend study. Virology Journal. 2022. 19(1), 166, doi: 10.1186/s12985-022-01898-9.
6. Huyen Dang Thi Thanh, et al. Epidemiology of acute diarrhea caused by rotavirus in sentinel surveillance sites of Vietnam, 2012–2015. Vaccine. 2018. 36(51), 7894-7900, doi: 10.1016/j.vaccine.2018.05.008.
7. Baumer P., et al. Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhea. Gut. 1993. 33, 753-758, doi: 10.1136/gut.33.6.753.
8. Lương Cao Đồng. Đánh giá hiệu quả điều trị tiêu chảy cấp do Rotavirus bằng Racecadotril ở bệnh nhi dưới 6 tuổi điều trị tại Khoa Nhi, Bệnh viện Quân y 103. Tạp chí Y-Dược học Quân sự. 2015. 5, 105-111.
9. Vũ Thị Huyền. Đánh giá kết quả điều trị hỗ trợ bệnh tiêu chảy cấp bằng thuốc kháng tiết đường ruột Hidrasec tại Khoa Nhi Bệnh viện Đa khoa Trung ương Thái Nguyên. Trường Đại học Y - Dược Đại học Thái Nguyên. 2010.
10. Liang Y., et al. Racecadotril for acute diarrhoea in children. Cochrane Database of Systematic Reviews. 2019. 12(12),CD009359, doi: 10.1002/14651858.CD009359.pub2.
11. Nguyễn Quốc Tính, Nguyễn Thị Cự. Đặc điểm tiêu chảy cấp do Rotavirus tại khoa Nhi, Bệnh viện Đa khoa tỉnh Bình Định. Tạp chí Y học lâm sàng. 2013. 18, 55-61, doi: 10.38103.18.9.